Creating a ceramic “window” in the skull could provide better access to the brain
What does analysis of the microbiome literature tell us about priorities and progress in the field?
Can a low-cost OCT device aid research and improve disease diagnosis in low-income settings?
When it comes to identifying cancerous tissue, is the “MasSpec Pen” mightier than the sword?
Improving cancer drugs by “manufacturing” therapeutic compounds using gold nanoparticle catalysts.
Over-reliance on rodent models could be leading drug discovery in the wrong direction
Gut mucus microbiota could lead to earlier diagnosis, or even prediction, of inflammatory bowel disease.
Research reveals a potential noninvasive predictor of bronchopulmonary dysplasia risk in preterm infants
A colorful mouse brain provides insight into autism spectrum disorder.
Eleftherios P. Diamandis
False discoveries have plagued biomarker research for years: don't trust everything you read.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.